New head and neck cancer drug "game changer"

A new type of cancer drug that wakes up the patient’s own immune system to fight tumours could be a game changer for tackling aggressive head and neck cancers, say experts.

The news announced today, 19th April at a conference supports the work of Professor Kevin Harrington.  Read the full news report here.